Hélène Salmon

Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

Hélène Salmon, Juliana Idoyaga, Adeeb Rahman et al. · Immunity · 2016 · 1.1K citations · Full text

Cancer Immunosurveillance, Therapeutic Pd-l1, Medicine +8

Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors

Hélène Salmon, Katarzyna Franciszkiewicz, Diane Damotte et al. · Journal of Clinical Investigation · 2012 · 1K citations · Full text

Immunology, Collagen Regions, Preferential Localization +24

Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy

Jérôme C. Martin, Christie Chang, Gilles Boschetti et al. · Cell · 2019 · 850 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Anti-tnf Therapy +12

<i>BRAF-V600E</i> expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

Marie‐Luise Berres, Karen Phaik Har Lim, Tricia Peters et al. · The Journal of Experimental Medicine · 2014 · 430 citations · Full text

Immunology, Immune Regulation, Pathology +24

Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification

Andrew M. Leader, John A. Grout, Bárbara Maier et al. · Cancer Cell · 2021 · 333 citations · Full text

Cancer Detection, Tumor Heterogeneity, Medicine +13